
Big pharma prepares for next patent cliff as blockbuster drugs revenue losses loom, says GlobalData
According to GlobalData’s latest report, “Blockbuster Drugs on Patent Cliffs,” there is set to be a smaller proportion of global drug sales which will have patent protection in 2030, a sharp drop compared to previous years.